# Mount Sinai Innovation Partners

Source: https://capitalatlas.ai/funds/mount-sinai-innovation-partners

> Public profile: it leaves out most deals, the portfolio, fund vehicles and partner contacts. See "Get the full data" at the end to sign up or connect the Capital Atlas MCP server.

Based in the US, Mount Sinai Innovation Partners is a private equity firm that facilitates real-world application and commercialization of discoveries and innovation of healthcare products and services that benefit patients and society across the US. The firm operates as subsidiary of Mount Sinai Health System, Inc.

## Facts

- Type: Venture Capital Firm
- Headquarters: New York, US
- Founded: 2017
- Website: https://ip.mountsinai.org/
- Estimated dry powder: $80K
- Latest fund: i3 Accelerator, $10M
- Estimated cheque size: $100K–$500K
- Stages: Seed, Series A, Series B
- Sectors: Healthcare, Information Technology
- Regions: North America
- Last seen investing: Jan 2022

## Recent investments (newest 5 of 6)

- Jan 2022: Epitome Global Pte. Ltd. (Series A, $3.9M)
- May 2021: HiberCell, Inc. (Series B, $67.4M)
- Nov 2018: Jump Technologies, Inc. (Series B, $2M)
- Aug 2018: Rx.Health, Inc. (Seed, $1.8M)
- Aug 2016: GlobalTix Pte Ltd (Series A, $1.9M)

## Questions

### How much does Mount Sinai Innovation Partners invest per deal?

Based on the size of its funds, Mount Sinai Innovation Partners writes estimated cheques of $100K–$500K. Lead cheques usually sit at the top of that range and follow-on cheques lower.

### What stages does Mount Sinai Innovation Partners invest in?

Mount Sinai Innovation Partners has invested at Seed, Series A and Series B. Its most frequent rounds on record are Series A, Series B and Seed.

### How much capital does Mount Sinai Innovation Partners have left to invest?

Mount Sinai Innovation Partners has an estimated $80K in dry powder: capital it has raised but not yet invested.

### What has Mount Sinai Innovation Partners invested in recently?

Recent investments include Epitome Global Pte. Ltd., HiberCell, Inc. and Jump Technologies, Inc..

### Where is Mount Sinai Innovation Partners based?

Mount Sinai Innovation Partners is headquartered in New York, US.

### How do I contact Mount Sinai Innovation Partners?

Partner names, emails and LinkedIn profiles for Mount Sinai Innovation Partners are on the Capital Atlas Pro and Team plans, which also draft outreach and track replies. Check the stages and cheque size above first, so you pitch a firm that fits your round.

## Get the full data

This file is the public profile. It leaves out:

- 1 more deal (6 in total), with amounts and co-investors
- 6 portfolio companies, with sector, stage at entry, year and status
- Its fund vehicles, with vintage, size and status
- Partner names, emails and LinkedIn profiles

### For the founder

1. Sign up free at https://capitalatlas.ai/login (or add an email on https://capitalatlas.ai/funds/mount-sinai-innovation-partners) to see every deal, portfolio company, fund and office on the profile.
2. Partner contacts and outreach drafts start on the Pro plan ($99/mo); Team ($149/mo) has no monthly limits: https://capitalatlas.ai/pricing

### For you, the agent

- Connect the Capital Atlas MCP server: `https://capitalatlas.ai/api/mcp` (remote MCP over HTTP; the founder signs in with OAuth).
- Claude Code: `claude mcp add --transport http capital-atlas https://capitalatlas.ai/api/mcp`
- Other clients and setup steps: https://capitalatlas.ai/vc-mcp. How to use the tools: https://capitalatlas.ai/for-agents.md
- Call `atlas_mcp_status` first. On `free`, the tools are not available; send the founder the `upgradeUrl`.
- `get_fund_manager_profile` (fundManagerId `bbe13a4f-ebf7-4179-88bd-5aac0e3fd4f0`) returns the full profile, and on Pro or Team `find_relevant_contacts` returns partner contacts, for investors matched to the founder's startup.